The neurogenic bladder (NB) covers all vesicosphincteric disorders (VSD) with neurological origin. These disorders are common; they always raise the question of their impact, whether medical by the risk on uro-nephrological system, or psychosocial with deterioration of the quality of life. Their recognition and therapeutic management and surveillance are therefore essential. Clinically, these VSD manifest by two classes of symptoms: urinary incontinence related to overactive bladder or sphincter dysfunction, urinary retention due to hypo or inactive bladder or sphincter hypertonicity. The neuro-perineal examination mark abolition of sacral reflexes, decreased perineal sensation and hypotonia of the anal sphincter. Urodynamic explorations allow to identify the pathophysiological mechanism of VSD. Cystomanometry allows the study of intravesical pressure during a progressive filling of the bladder with saline. The presence of involuntary contractions occurring at low volume defines detrusor overactivity (DO), reflecting the release of the automatic bladder which results in most cases in urge incontinence with leak emergency. Conversely, an underactive detrusor or detrusor-sphincter dysynergia (DVS) can be responsible for dysuria or retention. The treatment of neurogenic bladder has a dual challenge: ensuring patient comfort by avoiding symptoms altering quality of life such as urinary incontinence, urinary urgency and urinary frequency; preserve the future of uro-nephrological system by ensuring a correctly drainage of bladder and keeping a low pressure system in the interval between urination or drainages. The therapeutic methods are numerous. The detrusor overactivity usually responds to treatment with anticholinergics (Oxybutynin ++) and behavioral techniques (selfcatheterization +++). If that fails, the injection of botulinum toxin and surgical techniques (enterocystoplasty, Neuromodulation S3) can be proposed. The treatment of dysuria and retention is based on alpha-blockers that reduce urethral resistance, and para-sphincteric injections of botulinum toxin. Surveillance of neurogenic bladder is essential to diagnose complications incurred in the vital and functional prognosis of these patients. It is based on regular mictional catalogs, vesico-renal ultrasound, creatinine assays and urodynamic examinations. Systematic control of urinalysis is strictly unnecessary and can only lead to unwanted antibiotics selecting multi-resistant organisms